All Episodes

September 5, 2019 23 mins

In this first episode, we will be talking about the increased demand for immune globulin (IG) products and its effect on patient access. This is our first podcast episode of IG Living Advocate and a transition from our Readers Teleconferences. With this podcast, we have an opportunity for our readers to hear from healthcare experts on topics important to them. 

In this first episode, we will be talking about the increased demand for immune globulin (IG) products and its effect on patient access. Today, we have with us guest expert Patrick M. Schmidt, chief executive officer of FFF Enterprises, also known as triple F, and Nufactor, a Specialty Infusion Company. Patrick has been with FFF since its inception in 1988. In 1995, FFF launched Nufactor to address the high costs and access issues related to IG therapy. Patrick is recognized as a leader in the healthcare community, having introduced several industry firsts that have paved the way to create solutions to challenges faced by both healthcare providers and their patients.

Support the Show.

Mark as Played

Advertise With Us

Popular Podcasts

1. The Podium

1. The Podium

The Podium: An NBC Olympic and Paralympic podcast. Join us for insider coverage during the intense competition at the 2024 Paris Olympic and Paralympic Games. In the run-up to the Opening Ceremony, we’ll bring you deep into the stories and events that have you know and those you'll be hard-pressed to forget.

2. In The Village

2. In The Village

In The Village will take you into the most exclusive areas of the 2024 Paris Olympic Games to explore the daily life of athletes, complete with all the funny, mundane and unexpected things you learn off the field of play. Join Elizabeth Beisel as she sits down with Olympians each day in Paris.

3. iHeartOlympics: The Latest

3. iHeartOlympics: The Latest

Listen to the latest news from the 2024 Olympics.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.